James J. Ferguson

Chief Medical Officer at Cadrenal Therapeutics.

Ponte Vedra, FL
Cadrenal Therapeutics

Raised on Cadrenal Therapeutics filings

$16.8M

of $16.8M offered across 2 Form D filings

Form D filings: 2
Teammates: 8
Last filing: Jul 15, 2026

Company

Cadrenal Therapeutics

Biotech · Ponte Vedra, FL

Drugs for heparin-induced thrombocytopenia and clotting

Drugs for heparin-induced thrombocytopenia and clotting

Investors: 1
Founded: 2022

Investors: 1
Sector: Biotech
Founded: 2022
HQ: Ponte Vedra, FL

Cadrenal Therapeutics filings

Cadrenal Therapeutics Form D filings
Filed	Security	Sold of offered	Filing
Jul 15, 2026	Security to be acquired	$8.8M/ $8.8M	Form D
Apr 6, 2026	Security to be acquired	$7.9M/ $7.9M	Form D

Security to be acquiredFiled Jul 15, 2026Form D
$8.8M/ $8.8M
Security to be acquiredFiled Apr 6, 2026Form D
$7.9M/ $7.9M

Works with

Also named on Cadrenal Therapeutics filings

Quang X. PhamChairman of the Board Chief Executive Officer, Form D signerForm D signer Lee GoldenDirector Glynn WilsonDirector Matthew SzotChief Financial Officer Steven ZelenkofskeDirector Jeffrey S. ColeChief Operating Officer John P. SharpInterim Chief Financial Officer John R. MurphyDirector